Loading organizations...
§ Private Profile · Vancouver, BC, Canada
Medical technology company developing cold fiber laser devices for aesthetics, dermatology, and plastic surgery, focused on skin rejuvenation.
Acclaro Medical is a medical technology company based in Smithfield, Rhode Island, that develops and commercializes advanced laser systems for the aesthetic, dermatology, and plastic surgery markets. The enterprise primarily manufactures cold fiber fractional laser devices designed for skin rejuvenation, tissue resurfacing, and various anti-aging treatments. Its flagship product portfolio includes the FDA-cleared UltraClear and AuraLux systems, which are sold directly to dermatologists, plastic surgeons, and medical spas through a business-to-business capital equipment sales model. The venture-backed organization has raised $23 million in total funding to date to advance its proprietary 2910 nm fiber laser technology and support global clinical expansion. This capital includes a recent Series B financing round led by institutional investor Accelmed Partners alongside participation from 3E Bioventures Capital. Acclaro Medical was established in 2018 by co-founders Shlomo Assa and Helen Fang.
Acclaro Medical has raised $23.0M across 1 funding round.
Acclaro Medical has raised $23.0M in total across 1 funding round.
Acclaro Medical has raised $23.0M across 1 funding round. Most recently, it raised $23.0M Series B in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 29, 2025 | $23M Series B | Daniel Cohen | 3E Bioventures Capital | Announced |
Acclaro Medical has raised $23.0M in total across 1 funding round.
Acclaro Medical's investors include Daniel Cohen, 3E Bioventures Capital.